Truthout
Vaccines
Frontline Warehouse Workers Are Worried They’ll Be Passed Over for COVID Vaccine
Low-wage warehouse workers, many of whom are temporary, are demanding access to the vaccine.
As Vaccine Gains Approval, Hospitals Scramble Over Which Workers to Prioritize
Still, hospital officials say they’re confident that those who want the vaccine won’t have to wait long.
GOP Under Fire for Blocking Necessary Funds as COVID Vaccine Distribution Begins
Mitch McConnell has made clear that he will not approve relief funds without a liability shield for corporations.
Some Countries May Not Have COVID Vaccine Until 2022 as Richer Ones Hoard Supply
A growing movement is calling for the suspension of intellectual property rights to expand access.
Pharma Money Colors Operation Warp Speed’s Quest to Defeat COVID-19
The Trump administration has allowed executives to keep investments in companies profiting from their COVID-19 efforts.
Poorer Countries May Have to Wait Years for a COVID Vaccine
U.S. must act now and leverage its stake in vaccine development to prevent “global vaccine apartheid,” advocates say.
Pfizer CEO Dumped $5.6 Million in Stock on Day of Encouraging Vaccine News
A watchdog group has called for Pfizer and other pharmaceutical companies to freeze the sale of stocks by executives.
Days After Hopeful Pfizer Vaccine News, 82% of Doses Bought by Richest Nations
Mass purchases of the vaccine by the richest countries have left more than 85% of the global population without access.
Consumer Advocates Warn Pfizer Data Is Incomplete — Vaccine Is Still Months Away
Pfizer released promising but preliminary data on a potential COVID-19 vaccine into a charged post-election atmosphere.
Biden Says Vaccine News Is “Great,” But Warns Masks Are Still Needed
Many experts agree that, in a best-case scenario, widespread access to a vaccine won't happen until mid-2021.